Consensus Daxor Corporation NYSE

Stocks

DXR

US2394671034

Closed End Funds

Market Closed - NYSE 04:30:00 2026-08-31 pm EDT			5-day change	1st Jan Change
10.08 ^USD	-1.18%		-3.55%	-31.67%

Jul. 30	Daxor Launches Blood Testing Lab in Eastern Kansis	MT
Jul. 30	Daxor Corporation Initiates Outpatient Blood Volume Analysis Program in Kansas	CI

Evolution of the Average Target: Daxor Corporation

Evolution of the Target Price: Daxor Corporation

Changes in Analyst Recommendations: Daxor Corporation

522025b75e13cccd7db99ba40d34cf3._oq2-1gY0wf5xoq4Gza24XAAtZpQ8-pl_wHyTu5201c.htjbwzZqonaMs93MawLQtCA03PIIwp8Cjk2zIdYUngXK2dOjami5bYq35Q~2a23a9c6b7092203d242f6da14591761

Closed End Funds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
3I INFRASTRUCTURE PLC			+5.6%
PERSHING SQUARE USA, LTD.	-	-	+6.57%
Average			+6.09%
Weighted average by Cap.			+6.03%

See all sector performances

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.08USD

Average target price

22.50USD

Spread / Average Target

+123.23%

High Price Target

23.00USD

Spread / Highest target

+128.19%

Low Price Target

22.00USD

Spread / Lowest Target

+118.27%

Consensus Daxor Corporation NYSE

Stocks

DXR

US2394671034

Closed End Funds

Evolution of the Average Target: Daxor Corporation

Evolution of the Target Price: Daxor Corporation

Changes in Analyst Recommendations: Daxor Corporation

Closed End Funds

Analysts' Consensus

Analyst Consensus Detail

Consensus revision (last 18 months)